House Health Care - 2026-04-09 - 2:00PM
legislative committee (unnamed in transcript) · April 9, 2026
A legislative committee heard testimony on S.154, a bill about insurance coverage and an actuarial study of biomarker testing. Witnesses from the Department of Vermont Health Access, the Alzheimer’s Association, the American Cancer Society, and insurers described clinical benefits, costs, and recommended the bill be converted into an actuarial study to quantify fiscal impact.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.